| Syed Fiaz Quadri, MD | |
|
504 Medical Center Blvd, Conroe, TX 77304-2808 | |
| (713) 481-3544 | |
| (713) 432-0221 |
| Full Name | Syed Fiaz Quadri |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 41 Years |
| Location | 504 Medical Center Blvd, Conroe, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548265507 | NPI | - | NPPES |
| 220033033 | Other | TX | RAILROAD MEDICARE |
| 153487704 | Medicaid | TX | |
| 153487703 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | K1903 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Sugar Land Hospital | Sugar land, TX | Hospital |
| Chi St. Lukes' Brazosport Hospital | Lake jackson, TX | Hospital |
| St Joseph Medical Center | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8527956176 | 45 |
News Archive
Quality of life for disabled elderly people is most closely tied to two factors: a sense of dignity and a sense of control, according to a study by researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco.
BMG Pharma S.r.l. today is pleased to announce that it has signed an exclusive distribution agreement with Samyang Biopharmaceutical Corporation granting them the rights to promote, sell and market its novel mucositis management product GelX in the territory of South Korea.
Food proteins are nitrated through various processes. Just how these processes affect food allergies, however, is only now coming to light. The latest findings of a research project funded by the Austrian Science Fund FWF are being presented today at an international symposium in Italy. The findings show that in the case of a particular food protein the nitrated form can trigger a stronger allergic reaction than the non-nitrated form. At the same time, however, this nitrated form of the protein is better digested and therefore rendered "harmless".
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
› Verified 8 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316921026 PECOS PAC ID: 8527956176 Enrollment ID: O20040306000020 |
News Archive
Quality of life for disabled elderly people is most closely tied to two factors: a sense of dignity and a sense of control, according to a study by researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco.
BMG Pharma S.r.l. today is pleased to announce that it has signed an exclusive distribution agreement with Samyang Biopharmaceutical Corporation granting them the rights to promote, sell and market its novel mucositis management product GelX in the territory of South Korea.
Food proteins are nitrated through various processes. Just how these processes affect food allergies, however, is only now coming to light. The latest findings of a research project funded by the Austrian Science Fund FWF are being presented today at an international symposium in Italy. The findings show that in the case of a particular food protein the nitrated form can trigger a stronger allergic reaction than the non-nitrated form. At the same time, however, this nitrated form of the protein is better digested and therefore rendered "harmless".
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Syed Fiaz Quadri, MD Po Box 4677, Houston, TX 77210-4677 Ph: () - | Syed Fiaz Quadri, MD 504 Medical Center Blvd, Conroe, TX 77304-2808 Ph: (713) 481-3544 |
News Archive
Quality of life for disabled elderly people is most closely tied to two factors: a sense of dignity and a sense of control, according to a study by researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco.
BMG Pharma S.r.l. today is pleased to announce that it has signed an exclusive distribution agreement with Samyang Biopharmaceutical Corporation granting them the rights to promote, sell and market its novel mucositis management product GelX in the territory of South Korea.
Food proteins are nitrated through various processes. Just how these processes affect food allergies, however, is only now coming to light. The latest findings of a research project funded by the Austrian Science Fund FWF are being presented today at an international symposium in Italy. The findings show that in the case of a particular food protein the nitrated form can trigger a stronger allergic reaction than the non-nitrated form. At the same time, however, this nitrated form of the protein is better digested and therefore rendered "harmless".
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
› Verified 8 days ago
Michelle Hebert, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-432-1100 Fax: 713-432-0221 | |
Anne S. Witson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Emilie Rouah, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Peter Allen Powaser, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Jacqueline Elizabeth Monheit, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
David Houston Yawn, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 | |
Mary Ostrowski, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 713-481-3544 Fax: 713-432-0221 |